GlassScriptPhysician profile
Kenneth Price
NPI 1194257550
$3,725.33
in general payments reported to CMS, 2019-2025
19 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what 78% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $162 · 2022: $1,223 · 2023: $476 · 2024: $836 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,340.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $1,023.08 | 2022 | |
| Alcon Vision LLC | $492.84 | 2021-2025 | Clareon, Centurion, Tryptyr |
| Regeneron Healthcare Solutions, INC. | $416.21 | 2023-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $359.73 | 2023-2025 | Vabysmo |
| Abbvie INC. | $206.13 | 2024-2025 | |
| Sight Sciences, INC. | $199.50 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $197.60 | 2023-2025 | Syfovre |
| Astellas Pharma US INC | $141.23 | 2023-2025 | Izervay |
| Harrow Eye, LLC | $123.14 | 2024-2025 | Iheezo, Vevye |
| Rxsight INC | $117.65 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Genentech, INC. | $102.13 | 2023 | Vabysmo |
| Notal Vision, INC. | $97.37 | 2025 | Foresee Home |
| Alimera Sciences, INC. | $85.00 | 2024 | Iluvien, Yutiq |
| Bausch & Lomb Americas INC. | $44.66 | 2024-2025 | Xipere |
| Ani Pharmaceuticals, INC. | $41.14 | 2025 | Iluvien, Yutiq |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $22.39 | 2023 | Tecnis Iol |
| Thea Pharma INC. | $20.84 | 2024 | Iyuzeh |
| Oyster Point Pharma, INC. | $18.57 | 2025 | Tyrvaya |
| Tearlab Corp | $16.12 | 2024 | Scoutpro Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.